ClinConnect ClinConnect Logo
Search / Trial NCT05717959

Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device

Launched by NATIONAL CHENG-KUNG UNIVERSITY HOSPITAL · Feb 6, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Obstructive Sleep Apnea Mandibular Advancement Device Oropharyngeal Exercises

ClinConnect Summary

This clinical trial is studying the effects of combining oropharyngeal exercises (exercises for the throat and mouth) with a mandibular advancement device (a special mouthpiece that helps keep the airway open) in adults who have obstructive sleep apnea (OSA). The goal is to see if this combined treatment can help strengthen the muscles in the throat, improve how well they work, and reduce the severity of sleep apnea symptoms, making it easier for patients to breathe during sleep.

To participate in the trial, you need to be an adult over 20 years old who currently uses a mandibular advancement device for sleep apnea. However, this study is not for everyone; individuals with a body mass index (BMI) of 35 or higher, pregnant women, and those with certain health issues like severe lung disease or serious heart problems cannot participate. If you join the trial, you can expect to engage in specific exercises designed to help improve your throat muscle strength and endurance. This research is important as it could lead to better treatment options for managing sleep apnea and improving overall sleep quality.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • OSA patients
  • aged over 20 years old
  • wearing a MAD
  • Exclusion Criteria:
  • Body Mass Index (BMI) ≧ 35
  • Pregnancy
  • Severe obstructive or restrictive lung disease
  • Exercise with high-risk cardiovascular disease
  • History of central or peripheral neurological disease resulting in an inability to perform exercise prescriptions
  • Musculoskeletal or psychological disorders that prevent the performance of exercise prescriptions
  • Chronic illnesses that are ongoing or not yet controlled

About National Cheng Kung University Hospital

National Cheng Kung University Hospital is a leading academic medical institution in Taiwan, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that enhance patient care and medical knowledge. Committed to adhering to the highest ethical standards and regulatory guidelines, National Cheng Kung University Hospital fosters collaborations with researchers, healthcare professionals, and industry partners to drive the development of new therapies and improve health outcomes for diverse populations.

Locations

Tainan, , Taiwan

Patients applied

0 patients applied

Trial Officials

Ching Hsia Hung, PhD

Principal Investigator

National Cheng Kung University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials